FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
03-18-2019, 07:00 PM | #1 | |||
|
||||
Grand Magnate
|
BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2 Study in Progressive MS…
Zacks Small Cap Research - BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2 Study in Progressive MS… . . . enClear AstraZeneca vet Jennifer Butler takes charge of Innate Pharma’s US biz; C4 raids NIBR – Endpoints News . . . ProMIS ProMIS Neurosciences Announces Fiscal Year 2�18 Annual Results |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
EnClear Therapies Raises $2M in Seed Funding | ALS News & Research | |||
ProMIS Neurosciences Identifies Novel Therapeutic Epitope Target for ALS and Dementia | ALS News & Research | |||
Promis of Spring | Reflex Sympathetic Dystrophy (RSD and CRPS) |